
Anubis
12-year-old Labrador. Very good boy. Has T-cell lymphoma; is not defined by it. The story
Wed, Jun 10, 2026
Tue, Jun 9, 2026
Little response to CCNU. Break week planned next, then vinblastine; radiation oncology consult being arranged.
Tue, Jun 2, 2026
Protocol changed based on the sensitivity panel. Mupirocin added for the wound infection.
Mon, Jun 1, 2026
CD8+ peripheral T-cell lymphoma, stage IIIa. Asparaginase 0.60, mitoxantrone 0.59, lomustine 0.55; vincristine 0.15, doxorubicin 0.13.
Tue, May 26, 2026
Partial mass reduction. Wound culture submitted; antibiotics switched to trimethoprim sulfa.
Wed, May 20, 2026
Monoclonal T-cell receptor gamma amplification; no B-cell amplification.
Mon, May 18, 2026
Sample submitted for flow cytometry and drug sensitivity testing.
Fri, May 15, 2026
Round cell tumor with aggressive features (mitotic count 94). Immunophenotyping recommended.
Thu, May 14, 2026
Allergy medication stopped; prednisone begun ahead of chemotherapy.
Wed, May 13, 2026
Tue, May 12, 2026
Incisional biopsy collected from the ulcerated left inguinal mass, which had grown roughly fourfold despite antibiotics.
Mon, Apr 27, 2026
A swelling in the left inguinal area was first noticed at home. Early cytology read it as a reactive lymph node.